Gene Therapy for Chronic Granulomatous Disease in Korea

NCT00778882 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped This Korean Phase 1 study was Withdrawn more than 15 years ago and no data is available.

Conditions

Interventions

Sponsor

Helixmith Co., Ltd.